Your browser doesn't support javascript.
loading
Modelling the potential impact of adherence technologies on tuberculosis in India.
Arinaminpathy, N; Chin, D P; Sachdeva, K S; Rao, R; Rade, K; Nair, S A; Dewan, P.
Afiliação
  • Arinaminpathy N; Imperial College London, UK.
  • Chin DP; Bill and Melinda Gates Foundation, Seattle, WA, USA.
  • Sachdeva KS; Central TB Division, New Delhi.
  • Rao R; Central TB Division, New Delhi.
  • Rade K; World Health Organization, India Country Office, New Delhi, India.
  • Nair SA; Stop TB Partnership, Geneva, Switzerland.
  • Dewan P; Independent Consultant, Seattle, WA, USA.
Int J Tuberc Lung Dis ; 24(5): 526-533, 2020 05 01.
Article em En | MEDLINE | ID: mdl-32398203
ABSTRACT

BACKGROUND:

For patients taking standard first-line tuberculosis treatment, missing 10% or more of their doses increases the risk of relapse six-fold. Digital technologies offer new approaches to adherence support for TB patients. We estimated the potential impact of new adherence technologies in India.

METHOD:

We developed a mathematical model of TB transmission dynamics in India, capturing the independent effects of missed doses and treatment default on post-treatment recurrence. We simulated the impact of interventions to address both missed doses and treatment default in the public and private healthcare sector.

RESULTS:

Adherence interventions, if deployed optimally in the public sector alone, would reduce cumulative TB incidence by 7.3% (95% credible intervals [CrI] 4.7-11) between 2020 and 2030, and by 16% (95% CrI 11-23) if also deployed in the private sector. This impact is roughly proportional to the effectiveness of the interventions. Reducing missed doses reduced incidence by 12% (95% CrI 7.0-18), while reducing treatment default reduced incidence by 7.9% (95% CrI 3.2-13).

CONCLUSION:

Minimising missed doses is at least as important as promoting treatment completion. Our results suggest that emerging technologies to improve treatment adherence could have a substantial impact on TB incidence and mortality in India.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD Problema de saúde: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis / 4_tuberculosis Assunto principal: Tuberculose Tipo de estudo: Incidence_studies / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD Problema de saúde: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis / 4_tuberculosis Assunto principal: Tuberculose Tipo de estudo: Incidence_studies / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
...